Sponsor:
Johnson & Johnson Enterprise Innovation Inc.
Code:
NCT06667908
Conditions
Carcinoma, Non-Small-Cell Lung
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
JNJ-90301900
Durvalumab
Concurrent Chemo/Radiation Therapy (cCRT)
Concurrent Chemo/Radiation Therapy (cCRT): Carboplatin
Concurrent Chemo/Radiation Therapy (cCRT): Paclitaxel
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-04. This information was provided to ClinicalTrials.gov by Johnson & Johnson Enterprise Innovation Inc. on 2026-05-11.